Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach

European Archives of Oto-Rhino-Laryngology

Volumn 263, Issue 11, 2006, Pages 977-982

  García Berrocal, José Ramón ^a   Ibáñez, Andrés ^a   Rodríguez, Antonio ^a   González García, José Ángel ^a   Verdaguer, José María ^b   Trinidad, Almudena ^a   Ramírez Camacho, Rafael ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

6 Methylprednisolone; Immune mediated inner ear disease; Methotrexate; Transtympanic therapy

Indexed keywords

CORTICOSTEROID; FOLIC ACID; GLUCOCORTICOID RECEPTOR; LIDOCAINE; LIVER ENZYME; METHOTREXATE; METHYLPREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EARDRUM; FEMALE; HEARING; HUMAN; IMMUNE MEDIATED INNER EAR DISEASE; IMMUNOPATHOLOGY; INNER EAR DISEASE; LIVER DYSFUNCTION; MALE; NAUSEA; PATHOPHYSIOLOGY; PATIENT SELECTION; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REMISSION; STEROID THERAPY; SYMPTOMATOLOGY; SYRINGE; SYSTEMIC THERAPY; TOPICAL ANESTHESIA; VERTIGO;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; MALE; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROUND WINDOW; ROUND WINDOW, EAR;

EID: 33749019741     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-006-0096-9     Document Type: Article

References (28)

1. García-Berrocal JR, Ramírez-Camacho R (2002) Sudden sensorineural hearing loss: supporting the immunologic theory. Ann Otol Rhinol Laryngol 111:989-997
2. García-Berrocal JR, Ramírez-Camacho R, Lobo D, Trinidad A, Verdaguer JM (2006) Adverse effects of glucocorticoids therapy for inner ear disorders. ORL (Basel) (in press)
3. García-Berrocal JR, Ramírez-Camacho R, Millán I, Górriz C, Trinidad A, Arellano B, Lobo D (2003) Sudden presentation of immune-mediated inner ear disease: characterization and acceptance of cochleovestibular dysfunction. J Laryngol Otol 117:775-779
4. García-Berrocal JR, Ramírez-Camacho R, Trinidad A, Lobo D (2004) Glucocorticoids: the best therapy for immune-mediated inner ear disease. Curr Top Steroid Res 4:99-104
5. García-Berrocal JR, Ramírez-Camacho R, Vargas JA, Millán I (2002) Does the serological testing really play a role in the diagnosis of immune-mediated sensorineural hearing loss? Acta Otolaryngol 122:243-248
6. García-Berrocal JR, Trinidad A, Ramírez-Camacho R, Lobo D, Verdaguer JM, Ibáñez A (2005) Immunologic work-up study for inner ear disorders: looking for a rational strategy. Acta Otolaryngol 125:814-818
7. Harris JP, Weisman MH, Derebery JM, Espeland MA, Gantz BJ, Gulya AJ Hammerschlag PE, Hannley M, Hughes GB, Moscicki R, Nelson RA, Niparko JK, Rauch SD, Telian SA, Brookhouser PE (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 290:1875-1883
8. Hoffer ME, Kopke RD, Weisskopf R, Gottshall KR, Moore R, Allen KE, Wester D, Balaban C (2001) Use of the round window microcatheter in the treatment of Meniere's disease. Laryngoscope 111:2046-2049
9. Kilpatrick JK, Sismanis A, Spencer RF, Wise CM (2000) Low-dose oral methotrexate management of patients with bilateral Meniere's disease. Ear Nose Throat J 79:82-92
10. Light JP, Silverstein H (2004) Transtympanic perfusion: indications and limitations. Curr Opin Otolaryngol Head Neck Surg 12:378-383
11. Lobo D, Trinidad A, García-Berrocal JR, Verdaguer JM, Ramírez-Camacho R (2006) TNF-α blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis. Eur Arch Otorhinolaryngol DOI 10.1007/s00405-006-0027-9
12. Lunardi C, Bason C, Leandri M, Navone R, Lestani M, Millo E, Benatti U, Cilli M, Beri R, Corrocher R, Puccetti A (2002) Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 360:915-921
13. Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, Rahman MU (2005) Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum 53:337-342
14. Matteson EL, Tirzaman O, Facer GW, Fabry DA, Kasperbauer J, Beatty CW, McDonald TJ (2000) Use of methotrexate for autoimmune hearing loss. Ann Otol Rhinol Laryngol 109:710-714
15. Matteson EL, Fabry DA, Facer GW, Beatty CW, Driscoll CL, Strome SE, McDonald TJ (2001) Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Rheum 45:146-150
16. McCabe BF (1989) Autoimmune inner ear disease: therapy. Am J Otol 10:196-197
17. McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585-589
18. Nair TS, Kozma KE, Hoefling NL, Kommareddi PK, Ueda Y, Gong TW, Lomax MI, Lansford CD, Telian SA, Satar B, Arts HA, El-Kashlan HK, Berryhill WE, Raphael Y, Carey TE (2004) Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss. J Neurosci 24:1772-1779
19. Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1-17
20. Pitovski DZ, Drescher MJ, Drescher DG (1994) Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hear Res 77:216-220
21. Ramírez-Camacho R, García-Berrocal JR, Trinidad A, Martín Marero A, Buján J (2002) Actividad citotóxica coclear del cisplatino en animales de experimentación. Un estudio con microscopia electrónica de barrido. Acta Otorrinolaringol Esp 53:538-542
22. Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 12:426-430
23. Ryan AF, Harris JP, Keithley EM (2002) Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl 548:38-43
24. Shimazaki T, Ichimiya I, Suzuki M, Mogi G (2002) Localization of glucocorticoid receptors in the murine inner ear. Ann Otol Rhinol Laryngol 111:1133-1138
25. Silverstein H (1999) Use of a new device, the MicroWick™, to deliver medication to the inner ear. Ear Nose Throat J 78:595-600
26. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I (1996) Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75:468-488
27. Sismanis A, Thompson T, Willis HE (1994) Methotrexate therapy for autoimmune hearing loss: a preliminary report. Laryngoscope 104:932-934
28. Staecker H, Lefebvre PP (2002) Autoimmune sensorineural hearing loss improved by tumor necrosis factor-alpha blockade: a case report. Acta Otolaryngol 122:684-687